Form D · Pharmaceuticals
ARBOR PHARMACEUTICALS INC
Atlanta, 2Q · CIK 0001375746
Offering snapshot reported Dec 10, 2010 · SEC filing
- Reported sold
- $17.4M Offering amount: $17.4M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $1 Reported outside-investor minimum
- First sale
- Nov 5, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 10, 2010 | Initial | $17,415,000 | No comparison | 10 | SEC filing |
| Apr 20, 2010 | Initial | $4,600,000 | No comparison | 7 | SEC filing |
| Dec 22, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Sep 14, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-151731
Source: Form D, filed Dec 10, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Marianne Boskamp | Director |
| Allen Chao | Director |
| Jarrett Disbrow | Executive |
| Joshua Disbrow | Executive |
| John Donofrio | Executive |
| Michael Fedida | Director |
| Edward Schutter | Director, Executive |
| Todd Sone | Director |
| Jason Wild | Director, Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
980 Hammond Drive Suite 1250
Atlanta, 2Q, 30328
Atlanta, 2Q, 30328